Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy—A Multicenter Study
暂无分享,去创建一个
H. Calkins | F. Ruschitzka | A. Dello Russo | P. Platonov | C. Tondo | A. Saguner | S. Kany | H. Jensen | F. Duru | C. James | Jiangping Song | P. Compagnucci | M. Casella | Liang Chen | C. Brunckhorst | A. Müssigbrodt | G. Forleo | A. Gasperetti | S. Mathew | S. Costa | A. Svensson | N. Schenker | Jiang-ping Song
[1] P. Ungprasert,et al. Prevalence of atrial arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. , 2020, Journal of cardiovascular medicine.
[2] X. Qiu,et al. Five‐year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy , 2020, Journal of cardiovascular electrophysiology.
[3] A. Saguner,et al. Right atrial pathology in arrhythmogenic right ventricular dysplasia , 2019, Cardiology journal.
[4] Jeroen J. Bax,et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). , 2019, European heart journal.
[5] G. Marcus,et al. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment , 2019, Journal of cardiovascular electrophysiology.
[6] G. Hindricks,et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.
[7] Stefan L. Zimmerman,et al. Atrial Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy: Value of Quantitative Magnetic Resonance Analysis in Predicting Atrial Arrhythmias , 2018, Circulation. Cardiovascular imaging.
[8] G. Hindricks,et al. Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[9] P. Brugada,et al. Long-term outcome of pulmonary vein isolation in patients with paroxysmal atrial fibrillation and Brugada syndrome , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[10] A. Wilde,et al. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy. , 2016, Journal of the American College of Cardiology.
[11] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[12] A. Medeiros-Domingo,et al. Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia. , 2014, Circulation Journal.
[13] H. Calkins,et al. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2013, Heart rhythm.
[14] Y. Oade,et al. Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.
[15] J. Svendsen,et al. Abnormal atrial activation is common in patients with arrhythmogenic right ventricular cardiomyopathy. , 2011, Journal of electrocardiology.
[16] F. Marchlinski,et al. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia. , 2010, The American journal of cardiology.
[17] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.
[18] B. Maron,et al. Spontaneously Occurring Arrhythmogenic Right Ventricular Cardiomyopathy in the Domestic Cat: A New Animal Model Similar to the Human Disease , 2000, Circulation.
[19] J. Svendsen,et al. Atrial fibrillation as a clinical characteristic of arrhythmogenic right ventricular cardiomyopathy: Experience from the Nordic ARVC Registry. , 2019, International journal of cardiology.
[20] L. Bañez,et al. Editorial comment. , 2010, The Journal of urology.